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Dominant mutations in cardiac transcription factor genes cause human inherited congenital 
heart defects (CHDs); however, their molecular basis is not understood. Interactions between 
transcription  factors  and  the  Brg1/Brm-associated  factor  (BAF)  chromatin  remodelling 
complex suggest potential mechanisms; however, the role of BAF complexes in cardiogenesis 
is not known. In this study, we show that dosage of Brg1 is critical for mouse and zebrafish 
cardiogenesis. Disrupting the balance between Brg1 and disease-causing cardiac transcription 
factors, including Tbx5, Tbx20 and nkx2–5, causes severe cardiac anomalies, revealing an 
essential  allelic  balance  between  Brg1  and  these  cardiac  transcription  factor  genes.  This 
suggests that the relative levels of transcription factors and BAF complexes are important for 
heart development, which is supported by reduced occupancy of Brg1 at cardiac gene promoters 
in Tbx5 haploinsufficient hearts. our results reveal complex dosage-sensitive interdependence 
between transcription factors and BAF complexes, providing a potential mechanism underlying 
transcription factor haploinsufficiency, with implications for multigenic inheritance of CHDs. 
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T
he transcriptional regulation of organogenesis has been well 
studied, and in the developing heart, combinatorial interac-
tions between transcription factors are key to robust gene reg-
ulation1,2. Importantly, disease-causing mutations in several cardiac 
transcription factors are the underlying cause of human congenital 
heart defects (CHDs)2,3. Most of these mutations are predicted to 
cause  haploinsufficiency;  however,  the  mechanistic  basis  for  the 
aberrant gene expression that results from reduced transcription 
factor dosage is not known.
Mutations in cardiac transcription factor genes, such as TBX5, 
NKX2–5 and GATA4, all cause dominant inherited human CHD. 
These factors physically interact with each other, providing an effec-
tive mechanism for specific target activation and a potential expla-
nation for their common disease-related haploinsufficiency4–6. Tbx5, 
Nkx2–5 and Gata4 also interact with the Swi/Snf-like Brg1/Brm-
associated factors (BAF) chromatin remodelling complexes, in part 
via Baf60c, a cardiac-enriched subunit of the BAF complexes7. This 
interaction is key for the de novo induction of cardiac differentiation 
from embryonic mesoderm8, and depletion of Baf60c function leads 
to impaired heart development7.
Identification of Baf60c and other BAF complex subunits that 
co-assemble to form cell-type-specific complexes has revealed the 
importance of BAF complexes as instructive factors in differen-
tiation, rather than simply as chromatin-unwinding machines7,9–11. 
These specific BAF complexes perform discrete functions related to 
lineage specification and precursor differentiation. However, little is 
known about dosage sensitivity of tissue-specific BAF complexes or 
their links to DNA-binding transcription factors that are involved 
in similar processes.
Mammalian BAF complexes include one of the two ATPases, Brm 
or Brg1 (ref. 10). Brm is dispensible for development, whereas Brg1 
(also known as Smarca4) is absolutely essential for broad aspects of 
development in early mouse embryogenesis12,13. Thus, disrupting the 
function of Brg1 provides insights into the global function of BAF 
complexes during development. In the present study, we examined 
the role of Brg1 in heart development in mouse and zebrafish and 
tested its potential role in modulating the function of disease-related 
cardiac transcription factors. Our results reveal a dosage-sensitive 
interdependence between transcription factors and BAF complexes 
that modulates several aspects of heart formation. We conclude that 
the disruption of a delicate balance between CHD-causing transcrip-
tion factors and BAF complexes is likely to be a mechanistic cause of 
CHDs because of transcription factor haploinsufficiency.
Results
Brg1  is  critical  for  mouse  heart  development.  To  assess  the 
importance of Brg1 in the developing mammalian heart, we deleted 
Brg1 in developing ventricular myocytes, with a loxP-flanked Brg1 
allele (referred to here as Brg1f)14 and Nkx2.5::Cre, which is expressed 
mainly  in  ventricular  myocytes  from  E8.5  onwards,  with  rare 
sporadic activity in endocardial cells15,16 (Fig. 1a and Supplementary 
Fig. S1). This Brg1 deletion led to highly variable defects in heart 
formation  (Fig.  1b,c),  perhaps  partly  because  of  variable  and 
incomplete activity of the Cre-expressing transgene (Fig. 1a and 
Supplementary Fig. S1). Most embryos did not survive past E10.5; 
however, a few (two pups from over ten litters) Nkx2.5::Cre;Brg1f/f 
mice were born alive. Severely affected embryos had a loss of normal 
ventricular  chamber  morphology  (Fig.  1b),  whereas  the  least 
severely affected, which survived to birth, had dilated disorganized 
ventricles, ventricular septation defects and a double outlet right 
ventricle (Fig. 1c). Most embryos had reduced chamber size and 
impaired looping (Fig. 1d). Expression of several cardiac genes was 
defective in Nkx2.5::Cre;Brg1f/f embryos (Fig. 1d), including Nppa  
(a marker of chamber myocardium), Tbx5 (a transcription factor that 
regulates Nppa) and the trabecular growth factor Bmp10. Reduced 
Bmp10 expression has also been shown in the deletion of Brg1 using 
Sm22a::Cre, and has been determined to be a critical downstream 
effector of Brg1-dependent gene regulation17. Our deletion using 
Nkx2.5::Cre,  although  variable  in  its  effect,  uncovers  a  broader   
Brg1-dependent programme of gene expression than that observed 
with Sm22a::Cre, most likely because of the earlier expression of 
Nkx2.5::Cre. Other cardiac genes, such as Nkx2–5 and Actc1, were 
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Figure 1 | Brg1 is required for early mouse heart formation. (a) Activity of the Nkx2.5::Cre transgene, using the Z/EG or RYR reporter, at E8.5, 9.5, 11 
and 12.5. Inset for E9.5 embryo shows a ventral four-chamber view. For whole-mount pictures, green signal is the activity of the Z/EG reporter, whereas 
red signal is the bright-field illumination through a red filter. For the RYR reporter, a cryosection stained for anti-EYFP (green), alpha-tropomyosin (red) 
and 4,6-diamidino-2-phenylindole (blue) is shown. original magnification: ×25 (whole-mount pictures), ×100 (sections). (b) Frontal view of oPT 
reconstructions (left panels), lateral view of oPT reconstructions (middle panels) and histology (rightmost panels) of WT and Brg1 mutant (Nkx2.5::
Cre;Brg1f/f) mice at E9.5. Arrowhead shows thickened ventricular wall. (c) Histology of postnatal day (P) 1 hearts. Arrow shows membranous ventricular 
septal defect and double outlet right ventricle in the Nkx2.5::Cre;Brg1f/f heart. Close-up of the interventricular septum (right panels) shows disorganized 
septum formation. original magnification: ×100. (d) Gene expression in WT and Nkx2.5::Cre;Brg1f/f mice at E8.5 (Actc1) or E9.5 (all other genes) shows 
decreased Tbx5, Nppa, Bmp10 and Hand1 expression. la, left atrium; lb, limb bud; lv, left ventricle; ra, right atrium; rv, right ventricle; v, ventricle; v?, ventricle 
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expressed normally (Fig. 1d), indicating deregulation of a specific 
programme in Nkx2–5::Cre;Brg1f/f hearts.
We conclude that Brg1 regulates specific programmes of gene 
expression in the developing heart that are critical for differentia-
tion of cardiac myocytes and cardiac morphogenesis.
Brg1 is critical for zebrafish heart development. The BAF com-
plex is conserved throughout evolution10. Zebrafishes have a single 
BAF complex ATPase, brg1. young, a loss-of-function mutation of   
brg1 (refs 18, 19), results in defects in retinal neurogenesis and peri-
cardial oedema, which often indicates a defective heart function.   
We isolated a new mutation in brg1, brg1s481, which is predicted 
to be a null allele (Supplementary Fig. S2); this mutation creates 
a  premature  stop  codon,  predicting  a  truncation  at  amino-acid 
residue 252 (of 1,627), deleting all functional domains including 
the ATPase/SNF2 domain and the bromodomains. This mutation 
fails to complement the published yng allele18,19 and is phenocop-
ied by morpholino oligonucleotide (MO) treatment (see below), 
consistent with a null allele. These mutants formed a heart; how-
ever, after 48 h of development, the heart became hypoplastic and 
had severe arrhythmias with sporadic arrests in contraction (Fig. 
2a,b; Supplementary Movies 1 and 2). The survival of brg1 mutant 
embryos to a late stage is likely related to the presence of maternal 
brg1 transcripts19. To knock down brg1 in other transgenic lines, 
translation-inhibiting MOs20 were injected. Knockdown of brg1 by 
MO does not alter endocardial differentiation, and vascular devel-
opment  occurred  normally  (Supplementary  Fig.  S3).  However, 
the heart chamber displayed severe stenosis (Fig. 2c,d). Co-injec-
tion of an MO targeting p53 was used to investigate a role for cell 
death in the brg1 cardiac phenotype21. Injection of p53 MO into 
brg1 mutant embryos resulted in an identical cardiac phenotype to 
that observed in uninjected mutant siblings (Supplementary Fig. 
S3). Gene expression analysis (Fig. 2e) demonstrated that, although 
differentiation of both heart chambers occurred properly, brg1s481 
zebrafish had lost the regionalization of nppa expression, which 
marks ‘working’ myocardium in fish and mice22; this is reminis-
cent of the loss of Brg1 in the mouse. Expression of atrioventricu-
lar canal-specific genes, including bmp4, tbx2b and notch1b, was 
abnormal in brg1s481 embryos, suggesting patterning abnormalities 
in  brg1  mutant  zebrafish  embryos.  Expression  of  the  Na + /Ca +  +  
exchanger  (Ncx)  was  elevated  in  brg1s481  embryos,  which  could 
explain contractility defects in brg1s481 embryos23,24. We conclude 
that, in zebrafish, as in the mouse, brg1 is required for a specific 
programme essential for cardiac morphogenesis and patterning.
To uncover the cellular mechanisms underlying loss of brg1 in 
zebrafish, cardiomyocyte migration, proliferation and shape were 
analysed. During cardiac cone tilting, an early event in the forma-
tion of the zebrafish heart tube, atrial myocardium undergoes left-
directed anterior migration25 (Fig. 3a–c; Supplementary Movie 2). 
In brg1 morphants, anterior cardiomyocytes, especially those on the 
right side of the heart, displayed randomized trajectories (Fig. 3d–f; 
Supplementary Movie 3), resulting in the failure of proper heart 
jogging, which is indispensable for subsequent heart looping and 
chamber  formation.  We  monitored  the  growth  of  the  heart  by 
counting the number of cardiomyocytes at different time points 
(Fig. 3g–n). At early stages, cell numbers between control and brg1 
morphants were comparable (at 28 hpf, 166 ± 12 (n = 4) cardiomyo-
cytes in wild type (WT) hearts versus 145 ± 14 in brg1 morphants 
(n = 5)). As development proceeded, however, growth in myocardial 
cell number obviously lagged in brg1 morphants and appeared to 
halt by 48 hpf (251 ± 13 (n = 6) in WT hearts versus 173 ± 14 in brg1 
morphants (n = 4); Fig. 3o; Supplementary Movies 4 and 5).
During zebrafish heart development, confined myocardial cell-
shape changes are a key parameter in cardiac morphogenesis22. In 
WT embryos, outer curvature cardiomyocytes became flattened 
and  elongated  and  were  aligned  relative  to  each  other  (Fig. 3p; 
Supplementary Movie 6). In brg1s481 embryos, cardiomyocytes had 
a cuboidal shape throughout the heart (Fig. 3q; Supplementary 
Movie 7). Because of the altered and variable cell shape, it is dif-
ficult to assess cell size, and thus we have not quantified this param-
eter; however, cell size did not appear to be grossly altered. As the 
changes in cell shape require a balance between extrinsic (blood 
flow) and intrinsic (contractility) biomechanical forces22, we exam-
ined the circulation in brg1s481 embryo (Supplementary Movie 8).   
The circulation in mutant embryos was slower than that in WT 
embryos at 36 hpf, but still robust, suggesting that reduced circula-
tion did not cause the abnormal myocyte shapes. Rather, the cell-
shape changes in brg1 mutants may reflect either an intrinsic defect 
in myocardial morphogenesis and/or be secondary to abnormal 
heart contractility.
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Figure 2 | Loss of Brg1 leads to heart development defects in the 
zebrafish embryos. (a, b) Lateral views at 5 dpf of WT (a) and brg1s481  
(b) zebrafish embryos. Arrowhead in b shows pericardial oedema.  
(c, d) Frontal views of WT or brg1s481 zebrafish embryos at 48 hpf, showing 
myocardium, labelled with cmlc2:eGFP (c), and endocardium, labelled with 
flk1:eGFP (d). original magnification: ×100. (e) Cardiac gene expression 
in WT and brg1s481 zebrafish embryos for indicated transcripts (left panels, 
top to bottom: cmlc2, amhc, bmp4 and notch1b; right panels, top to bottom: 
vmhc, nppa, tbx2b and ncx). White arrow shows normal absence of nppa 
at the atrioventricular (AV) junction, grey triangles show staining of 
pacemaker cells, red brackets show normal and expanded domains of  
AV canal markers (bmp4 and tbx2b). original magnification: ×200.ARTICLE
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CHDs in Brg1 haploinsufficient mice. The defects upon cardiac-
specific deletion of Brg1 and the phenotype of brg1 zebrafish show 
that Brg1 is critical for specific aspects of cardiac gene expression. 
As Brg1 + / −  mice are underrepresented after birth13, we hypothesized 
that the partially penetrant lethality in Brg1 + / −  mice might be due 
to CHDs. We found that 50% of Brg1 + / −  mice died before 3 weeks 
of age (compared with 0% in WT controls), and in neonatal mice 
(n = 10)  we  found  CHDs  such  as  dilated  hearts  (5/10),  muscular 
ventricular septal defects (2/10) and incomplete closure of the atrial 
septum (4/10), a condition known as patent foramen ovale (Fig. 4a).   
Specific  heterozygous  deletion  of  Brg1  in  ventricular  myocytes   
(with Nkx2.5::Cre) and cardiac precursors (with Mef2cAHF::Cre26) 
also led to CHDs, indicating that these are not due to nonspecific 
effects of loss of Brg1 outside the heart (Supplementary Fig. S4). The 
lack of severe defects in Nkx2.5::Cre;Brg1fl/ +  mice (in which hetero-
zygous loss of Brg1 is only in ventricular myocytes) indicate that the 
defects in Brg1 + / −  mice are likely to result from combined defects in 
multiple cardiac cell types. Brg1 + / −  mice that survived the neonatal 
period had structurally normal hearts, but we also identified specific 
abnormalities in heart function in adult Brg1 + / −  mice, as determined 
by high-frequency ultrasound and electrical function (Fig. 4b–d). 
Haemodynamic  anomalies  consisted  of  predominantly  impaired 
cardiac relaxation, as determined primarily by a decrease in E-wave 
amplitude (Fig. 4b,d). Defects in cardiac electrical function were also 
found  in  surviving  Brg1 + / −   mice  by  telemetry  electrocardiogram 
(ECG), which included atrioventricular block, mild prolongation of 
the QRS complex (indicative of slowed conduction) and occasional 
sinus node dysfunction (resulting in an irregular heart beat; Fig. 
4b–d). We conclude that Brg1 haploinsufficiency predisposes mice to 
CHDs and abnormal heart function. This important result identifies a 
dosage requirement for BAF complexes in specific aspects of cardiac 
morphogenesis and functional maturation, and suggests a potential 
mechanistic link to disease-causing mutations in human CHD.
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Figure 3 | Defective cardiomyocyte migration and cell shape in 
zebrafish brg1 mutants. (a–f) Imaging of atrial cell migration in WT 
embryos (a–c) and brg1 morphants (d–f). (a, b, d, e) Dorsal views of 
heart in Tg(cmlc2:eGFPtwu34) embryos between 18 and 21 hpf; dotted white 
lines indicate the embryonic midline. (c, f) Arrows of different colours 
indicate the trajectories of individual cells. original magnification: ×200. 
(g–o) measurement of cardiomyocyte numbers. Three-dimensional 
reconstructions of the nuclear DsRed signal from Tg(cmlc2:dsRedExp-nuchsc4) 
embryos are shown (g–n). The 28 hpf embryos (g, h) are shown in dorsal 
view, the 36 hpf (i, j), 48 hpf (k, l) and 72 hpf (m, n) embryos are shown in 
anterior views. (o) Quantitation of cardiomyocyte cell numbers. Data are 
mean ± s.d., n = 5–8 embryos; *P < 0.05 by t-test. original magnification: 
×400. (p, q) Three-dimensional assessment of cell morphologies in 
Tg(cmlc2:eGFPtwu34)-expressing hearts that exhibit mosaic expression of 
Tg(cmlc2:dsRedExp-nuchsc4). Arrows point to representative cells. (p) WT 
cells transplanted; (q) brg1s481 cells transplanted. original magnification: 
×400. A, atrium; L, left; R, right; V, ventricle. 
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Figure 4 | CHDs in Brg1 heterozygous null mice. (a) Histology of postnatal 
day 0 WT (left panels) and Brg1 + / −  hearts (right panels), showing dilated 
chambers, muscular ventricular septal defect (VsD) and patent foramen 
ovale (PFo) in Brg1 + / −  hearts. Top and bottom panels are planes of section 
of the same heart at the level of the outflow tract (top panels) and at the 
level of the atrial septum (bottom panels). original magnification: ×50.  
(b) Doppler waveforms of flow at the mitral valve of adult WT and  
Brg1 + / −  mice, showing altered E and A wave amplitudes in Brg1 + / −  mice. 
(c) ECG telemetry in WT and Brg1 + / −  mice, showing prolonged PQ interval, 
sinus pause and second-degree atrioventricular block in Brg1 + / −  mice.  
(d) Quantitation of selected parameter in WT (grey bars) and Brg1 + / −  
(black bars) mice. units of measure are indicated in parentheses next to 
the graphed metric title. Data are mean ± s.d.; n = 5; *P < 0.05. la, left atrium;   
lv, left ventricle; ra, right atrium; rv, right ventricle. ARTICLE     
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Brg1 genetically interacts with transcription factor genes. The 
morphological  and  physiological  heart  defects  in  Brg1 + / −   mice 
are reminiscent of those in Tbx5 haploinsufficient mice4,27,28. We 
hypothesized that Brg1 might be a critical determinant of the dos-
age sensitivity of Tbx5. To look for a genetic interaction between   
Tbx5  and  Brg1,  we  generated  mice  heterozygous  for  both  Tbx5  
and Brg1 (Brg1 + / − ;Tbx5del/ +  mice). Compared with Brg1 + / −  or Tbx5del/ +  
mice, which had normal heart morphologies at E12.5, all Brg1 + / − ; 
Tbx5del/ +   mice  (n = 6)  had  severe  defects  in  heart  formation  at   
this  stage,  including  hypoplastic  left  ventricle  and  dilated  atria   
(Fig.  5a,b).  Although  Brg1 + / − ;Tbx5del/ +   hearts  appeared  relatively 
normal at E11.5, this genetic interaction was evident at the level of 
Nppa gene expression at E9.5, which was expressed at normal levels 
in Brg1 + / −  mice, at slightly reduced levels in Tbx5del/ +  mice, but was 
undetectable in Brg1 + / − ;Tbx5del/ +  mice (Fig. 5a). Trivial explanations 
might be that, in Brg1 + / − ;Tbx5del/ +  mice, the expression of Tbx5 is 
much lower than in Tbx5del/ +  or Brg1 + / −  mice or that expression 
of its interacting partners (Nkx2–5, Gata4) is lower, predisposing 
the mice to more severe CHDs; this mechanism was discounted by 
quantitative reverse transcription-PCR and microarray analysis that 
showed similar levels of Tbx5, Nkx2–5 and Gata4 messenger RNA 
(mRNA) in Brg1 + / −  and Brg1 + / − ;Tbx5del/ +  hearts at E11.5 (Supple-
mentary Fig. S5 and Supplementary Data 1).
In zebrafish, mutation of tbx5 in the heartstrings mutant29 leads to 
defects in heart looping and progressive deterioration of the heart. 
The similarity between tbx5 and brg1 mutants in the fish raised the 
possibility that genetic interactions between these two genes may 
exist also in zebrafish. We performed double knockdown of brg1 
and tbx5 via MOs. When 1 ng brg1 or tbx5 morpholino was injected, 
the  heart  developed  normally  in  all  cases  (Fig.  5c).  In  contrast,   
co-injection of brg1 and tbx5 morpholino (1 ng each) resulted in 
52% of embryos displaying a severe heartstrings-like phenotype and 
44% of embryos having a milder unlooped, tube-like heart pheno-
type (n = 120; Fig. 5c), demonstrating a clear and conserved genetic 
interaction between brg1 and tbx5.
We utilized the variable dose dependency of other critical car-
diac transcription factors in the mouse to test further genetic inter-
actions with Brg1. Although Tbx5 haploinsuffiency in the mouse 
mimics CHDs in humans4, Nkx2–5 heterozygous mice display only 
very mild aspects of CHDs caused by human NKX2–5 mutations30,31, 
and Tbx20 haploinsufficiency does not result in any detectable heart 
defects32. We generated compound heterozygous mice for Brg1 and 
for either Tbx5, Nkx2–5 or Tbx20; all mouse mutations are loss-of-
function alleles with no known dominant activity. In all three cases, 
dramatic and specific defects in heart formation were observed in 
all compound heterozygous mice (n = 4–8) at E12.5 (Fig. 5d), and no 
compound heterozygous mice survived past E14.5. Defects included   
severe  loss  of  cardiac  cushion  formation  (Tbx5 + / − ;Brg1 + / −   and 
Brg1 + / − ;Nkx2–5 + / − ), thinned atrial walls (Tbx5 + / − ;Brg1 + / − , Tbx20 + / − ; 
Brg1 + / − ),  hypoplastic  ventricles  (Tbx5 + / − ;Brg1 + / − ,  Nkx2–5 + / − ; 
Brg1 + / − ) and thinned ventricular walls (Nkx2–5 + / − ;Brg1 + / − , Tbx20 + / − ; 
Brg1 + / − ). gata5 mutant fishes also have heart defects33, and mouse 
Gata4, the functional homologue of zebrafish gata5, interacts with 
BAF complexes7,8; we also observed an interaction of brg1 and gata5 
low-dose  MOs,  supporting  a  more  general  importance  of  dose-
dependent  interactions  between  Brg1  and  cardiac  transcription   
factors (Supplementary Fig. S2).
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WT Brg1+/– Tbx5del/+ Tbx5del/+;Brg1+/– Figure 5 | Genetic interactions between Brg1 and cardiac transcription 
factor genes. (a) Brg1 and Tbx5 genetically interact. The top row shows an 
external view of hearts from E12.5 WT, Brg1 + / − , Tbx5del/ +  and Brg1 + / − ; 
Tbx5del/ +  embryos; the bottom row shows expression of Nppa at E9.5 
for the same genotypes. original magnification: ×50. (b) Histology of 
E11.5 WT and Brg1 + / − ;Tbx5del/ +  embryos. Brg1 + / −  or Tbx5del/ +  embryos are 
indistinguishable from WT. Asterisk indicates atrioventricular cushion and 
arrowhead indicates interventricular septum. original magnification: ×100. 
(c) Brg1 and Tbx5 interactions in zebrafish. Tg(cmlc2:eGFPtwu34) control (WT)   
or mo-injected embryos are shown in ventral–anterior views at 72 hpf. 
Brg1mo: mo directed against Brg1; Tbx5mo: mo directed against Tbx5. 
All mos were injected at 1 ng. Percentages in the Brg1mo and Tbx5mo 
show the percentage of normal hearts. The graph shows the percentage of  
phenotypes observed in double knockdown experiments (n = 74, 91 and 126  
for brg1, tbx5 and brg1 + tbx5 morpholino injections, respectively). original 
magnification: ×400. (d) Brg1 genetically interacts with Tbx5, Nkx2–5 and 
Tbx20. Histology of E12.5 hearts shows specific defects in Brg1 + / − ;Tbx5del/ + , 
Brg1 + / − ;Nkx2–5 + / −  and Brg1 + / − ;Tbx20 + / −  embryos, compared with WT. 
Nkx2–5 + / −  and Tbx20 + / −  hearts are structurally identical to WT hearts. 
Asterisk indicates atrioventricular cushion and arrow indicates atrial 
septum (as). original magnification: ×100. (e) summary of microarray 
analysis performed on E11.5 hearts of the indicated genotypes. Venn 
diagrams show the number of altered transcripts for each genotype,  
using a statistical cutoff of P < 0.01 and fold change  > 0.3. la, left atrium;  
lv, left ventricle; ot, outflow tract; ra, right atrium; rv, right ventricle. ARTICLE
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These strong genetic interactions between Brg1 and cardiac tran-
scription factor genes in mouse and zebrafish demonstrate a finely 
regulated  interdependency  between  cardiac  DNA-binding  tran-
scription factors and BAF chromatin remodelling complexes.
Programmes regulated by Brg1 and cardiac transcription factors. 
The genetic interaction between Brg1 and cardiac transcription fac-
tor genes could be a result of a genetic programme common to all 
transcription factors that is sensitive to Brg1 levels or, alternatively, 
Brg1  may  potentiate  each  transcription  factor’s  specific  genetic   
programme. To address this question, we performed transcriptional 
profiling of E11.5 hearts from mice heterozygous for deletions of 
Brg1, Tbx5 or Nkx2–5, and mice that were compound heterozygotes 
for Brg1 and each transcription factor gene. We observed varying 
degrees of overlap between the sets of genes that were altered by 
decreased dosages of Brg1, Tbx5 and Nkx2–5, indicating some speci-
ficity to the programmes that are regulated by these factors (Fig. 5e 
and Supplemental Data 1, and quantitative RT-PCR (QRT-PCR) 
validation in Supplementary Fig. S5). Clustering analysis defined 
specific groups of genetic interactions (Fig. 6a,b), indicating con-
siderable complexity to the genetic interactions between Nkx2–5 
or Tbx5 and Brg1. For example, some genes were altered mostly in 
compound heterozygous hearts (clusters a, m, g, t). These genes are 
more resistant to an imbalance between Brg1 and the DNA-binding 
factors, but still rely on the balance of Brg1 and Tbx5 or Nkx2–5 for 
their normal regulation. Imbalance in the expression of these sets of 
genes is likely to be key for the compound heterozygous phenotype 
observed between Brg1 and Tbx5 or Nkx2–5.
Perhaps more surprisingly, many genes that were altered in single 
heterozygous (Nkx2–5lacZ/ + , Brg1 + / −  or Tbx5del/ + ) hearts compared 
with WT hearts were not significantly altered in compound hetero-
zygous  (Nkx2–5lacZ/ + ;Brg1 + / −   or  Tbx5del/ + ;Brg1 + / − )  hearts  (clusters 
d, e, l, n, o and u in Fig. 6a,b). One possible interpretation of this 
striking interaction is that the relative levels of Nkx2–5 (or Tbx5) 
and Brg1 need to be maintained for normal expression of this set of 
genes, and that loss of one allele of either Nkx2–5 or Brg1 in single 
heterozygotes upsets this balance, leading to an allelic ratio of 2:1 or 
1:2; however, in Nkx2–5lacZ/ + ;Brg1 + / −  hearts the balance is restored 
(a 1:1 allelic ratio). This implies that the relative levels between the 
DNA-binding factors (Tbx5 and Nkx2–5) and Brg1 is critical for a 
large set of genes.
The types of genes identified in the transcriptional profiling assays 
were from a wide range of functional classes, as exemplified from 
statistical exploration of Gene Ontology classifications that revealed 
broad classes of transcripts enriched in specific clusters (Fig. 6). 
Several genes important for heart development were identified in 
the different clusters of differentially regulated genes, including sev-
eral previously identified as altered in Nkx2–5- or Tbx5-deficient 
hearts31,34,35. One particular novel set of transcripts was of interest: 
in Nkx2–5lacZ/ +  and Brg1 + / −  hearts, we measured a clear increase in 
expression of several genes associated with the haematopoietic pro-
gramme, including key regulators of this programme such as Gata1, 
Klf1 and Tal1. This implies that Nkx2–5/Brg1 suppresses haemat-
opoietic differentiation in the embryonic heart.
It is difficult to precisely link the contribution of the different 
genetic programmes regulated by individual factor dosage and com-
binatorial dosage to the heart defects in each genetic modification, 
especially with only one snapshot in developmental time. Further-
more, many of the affected transcripts are likely to be due to indirect 
effects. However, it is clear that overlapping programmes are sensi-
tive to the dosage of Brg1 and the cardiac transcription factor genes.
Reduced promoter occupancy by Brg1 in mutant hearts. Genetic 
interactions between Brg1 and cardiac transcription factors may 
reflect a direct physical interaction that is sensitive to the dosage 
of each factor, in one or multiple cell types, as well as interactions 
between various cell types in which one factor is haploinsufficient, 
and another cell type in which the interacting factor is haploinsuf-
ficient. To address the former possibility, we performed chromatin 
immunoprecipitation  (ChIP)  for  Brg1  on  E9.5  hearts  from  WT, 
Tbx5del/ + , Brg1 + / −  and Tbx5del/ + ;Brg1 + / −  embryos at the cardiomy-
ocyte-specific Nppa and Gja5 promoters (Fig. 7a). We found that 
at the Nppa gene, Brg1 occupancy was reduced in Brg1 + / −  hearts, 
consistent with a limiting amount of Brg1, and that at both Nppa 
and Gja5, Brg1 occupancy was reduced in Tbx5del/ +  hearts, indicat-
ing that reduced levels of Tbx5 directly result in reduced occupancy 
of Brg1 (Fig. 7b). Brg1 occupancy on both promoters was further 
reduced in Tbx5del/ + ;Brg1 + / −  embryos, suggesting that the interde-
pendency of Tbx5 and Brg1 is partly compensated by interactions 
with  other  factors,  perhaps  other  transcription  factors  that  can 
interact with BAF complexes. These results provide a mechanism 
for some of the dosage-related relationships between Tbx5 and Brg1 
on Tbx5 target genes, and support the notion that at least some of 
the effects of the genetic interaction between Tbx5 and Brg1 reflect 
cell-autonomous direct interactions.
Brg1-dependent transcriptional activation in vitro. We investi-
gated whether transcriptional activation of cardiac genes directly 
requires the function of Brg1. We previously showed that Tbx5, 
Nkx2–5, Gata4 and the BAF complex subunit Baf60c can activate 
cardiac gene expression in non-cardiac mesoderm8. We found that 
co-transfection of NIH3T3 fibroblasts with Tbx5, Nkx2–5 and Gata4 
expression constructs could robustly induce de novo the cardiac-
specific gene Nppa, a marker of differentiated cardiomyocytes, the 
promoter of which is well characterized as a target of these transcrip-
tion factors (Fig. 7c) (refs 4, 36). As Baf60c is expressed in NIH3T3 
fibroblasts, exogenous Baf60c did not enhance the effect (data not 
shown). Other cardiac genes examined were not induced by this 
combination of factors. To determine the requirement for Brg1 in 
the de novo activation of Nppa, we depleted Brg1 with endoribo-
nuclease  prepared  small  interfering  RNAs  (esiRNAs)37.  esiRNAs 
directed against Brg1 resulted in an ~50% decrease in Brg1 protein 
level (Fig. 7d). Decreased levels of Brg1 completely prevented Nppa 
activation by cardiac transcription factors (Fig. 7e,f), suggesting that 
this transcriptional activation is dependent on limiting amounts of 
functional Brg1-containing BAF complexes.
Discussion
We demonstrated a critical, conserved and dosage-sensitive role for 
the BAF chromatin remodelling complex ATPase Brg1 in vertebrate 
heart development. Our results further show an important interde-
pendency between BAF complexes and disease-related cardiac tran-
scription factors, which suggests a mechanism for CHDs caused by 
mutations in these transcription factor genes and implications for 
multigenic inheritance of CHDs.
In mouse and zebrafish, Brg1 is required for important and spe-
cific aspects of heart development. In particular, chamber morpho-
genesis is disrupted in both mice and fish lacking Brg1, and prolif-
eration of cardiac progenitors is reduced. A key subset of cardiac 
genes was affected by the loss of Brg1, consistent with specific roles 
for BAF complexes in differentiation of other cell types9,14,19,38–42.   
In many of these cases, Brg1 is required for differentiation after 
specification. Our results support a clear role for Brg1 in cardiac 
differentiation. As the function of Gata4, Nkx2–5 and Tbx5 relies 
on BAF complexes, in part via Baf60c7,8, loss of Brg1 likely affects 
target genes primarily by reducing the activation potential of car-
diac transcription factors. Loss of brg1 in zebrafish demonstrates a 
strikingly conserved role for BAF complexes in vertebrate cardiac 
development. The morphogenetic and gene expression defects in 
brg1 mutant fish closely resemble that seen in mice lacking Brg1, 
suggesting that the gene networks regulated by BAF complexes are 
well conserved in vertebrate evolution.ARTICLE     
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Notably, mice heterozygous for a deletion of Brg1 have heart 
defects. This important finding indicates that Brg1 is haploinsuffi-
cient in the heart. Haploinsufficiency of Brg1 has been reported in 
the brain13 and immune system43, indicating that certain cell types 
are sensitive to the dosage of Brg1. The important dose dependency 
of Brg1 function in cardiogenesis shows that, as for DNA-binding 
transcription factors, normal formation of the heart relies on precise 
levels of functional BAF complexes. Furthermore, the genetic inter-
action between Brg1 and several cardiac transcription factor genes 
shows that transcription factor function is intimately linked to levels 
of Brg1. The resulting CHDs are likely to reflect these interactions 
in multiple cell types. Our promoter occupancy data indicate that, 
for at least a portion of co-regulated genes, a direct cell-autonomous 
dosage-related interaction exists. Specific genetic programmes are 
sensitive to the dosage of each transcription factor, and there is con-
siderable complexity in the genomic regulation of gene expression 
by Brg1 and cardiac transcription factors. In some cases, a clear 
interrelationship exists between the dosage effects of either factor, 
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Figure 6 | Clustering analysis of altered gene expression. (a) Clustering analysis of altered transcripts from Nkx2–5 + / −  (n), Brg1 + / −  (B) and compound 
heterozygotes, Nkx2–5 + / − ;Brg1 + / −  (nB) E11.5 hearts. Heart maps for all statistically significant clusters indicate the average value for each group.  
All biological replicates within groups were included in cluster analyses; figures were made by taking the mean for each group. Box plots for a selection 
of clusters show the median (middle line), third and first quartile (top and bottom (hinges) of the boxes); the ‘whiskers’ extend 1.5× the length of the box, 
with other points (outliers) plotted as circles. statistically significantly overrepresented Gene ontology (Go) categories (adjusted P < 0.01) are shown. 
Genotypes are shown on the x axis; y axis shows log 2 fold change from WT. (b) Clustering analysis as in B, but for transcripts from Tbx5del/ +  (T),  
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resulting in a more profound effect in embryos haploinsufficient for 
Brg1 and Nkx2–5 or Tbx5. In other words, diminution of levels of 
one factor will reduce that factor’s chance of interaction with BAF 
complexes, and this can be accentuated when Brg1 levels are also 
lower. Our molecular data support a model (Fig. 8, model a) for 
direct interactions between Brg1 and cardiac transcription factors, 
and imply that reduced recruitment of BAF complexes may be a 
significant molecular mechanism underlying transcription factor 
haploinsufficiency in congenital heart disease.
The observation that expression levels of several transcripts that 
are altered in heart heterozygous for a null allele of Nkx2–5, Tbx5 
or Brg1 are restored to normal or near-normal levels in Nkx2–5lacz/ + ; 
Brg1 + / −  or Tbx5lacz/ + ;Brg1 + / −  compound heterozygous hearts indi-
cates that for some genes, the relative allelic balance of Nkx2–5  
(or Tbx5) and Brg1 may be more important than their absolute   
levels. The mechanism underlying this dosage interdependence is 
not known, but may include increased potential for interaction with 
other proteins that would alter the functional output on target genes 
(Fig. 8, model b). Thus, haploinsufficiency of cardiac transcription 
factors in CHDs is predicted to result in an imbalance between tran-
scription factors and BAF complexes, likely resulting in impaired 
transcriptional activation at loci sensitive to this balance. The reason 
for distinct dosage-sensitive responses from one group of genes to 
the next is not known, but perhaps the chromatin status of some 
genes requires different dosage-related interactions between BAF 
complexes and DNA-binding transcription factors.
We  cannot  discern  which  specific  group  of  genes,  between 
those  that  respond  more  in  the  compound  heterozygotes,  those 
that return to WT levels in compound versus single heterozygotes, 
or combinations thereof, is responsible for the phenotypic output 
of transcription factor or Brg1 haploinsufficiency. It is likely that 
deregulation of many different genes in various functional classes 
would be responsible for the complex altered morphology and func-
tion that we observe.
In conclusion, we demonstrated a critical requirement for Brg1 in 
the development of the vertebrate heart, and importantly showed that 
there exists a fine balance between Brg1 levels and those of cardiac 
transcription factors that have been implicated in human CHD. The 
genetic interactions between Brg1 and cardiac transcription factor 
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Figure 8 | Models for the interaction between DNA-binding transcription 
factors and Brg1. Two models for the interaction between DnA-binding 
transcription factors and Brg1. model (a) is based on the dosage-sensitive 
interrelationship between DnA-binding transcription factors (represented 
by Tbx5) and Brg1. In Brg1 + / −  hearts, some Tbx5-binding events are not 
accompanied by concomitant Brg1 binding, resulting in decreased gene 
expression. In Tbx5 + / −  hearts, Brg1 can only interact with one of two 
potential Tbx5-binding events, but may still interact more weakly with 
other DnA-binding transcription factors (X). In Tbx5 + / − ;Brg1 + / −  hearts, 
all quantitative interactions are impaired, leading to further reduction in 
target gene expression. model (b) is based on the normalization of gene 
expression in Tbx5 + / − ;Brg1 + / −  and Nkx2-5 + / − ;Brg1 + / −  hearts, and is based on 
the allelic balance between the two genes. In Brg1 + / −  hearts, the ratio of  
Tbx5 to Brg1 alleles is now 2:1, which allows some Tbx5-binding events to 
interact with other factors, including a hypothetical repressor protein (Y).  
In Tbx5 + / −  hearts, the ratio of Tbx5 to Brg1 alleles is now 1:2, which  
allows some Brg1-binding events to interact with other factors, including a 
hypothetical repressor or sequestrating protein (Z). In Tbx5 + / − ;Brg1 + / −  hearts, 
the balance is restored to 1:1, eliminating the potential for other interactions.
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Figure 7 | Direct interactions between Brg1 and cardiac transcription 
factors. (a) Diagram indicating the location of primer pairs for 
amplification of immunoprecipitated chromatin-associated DnA for Nppa 
and Gja5. Locations of conserved T-box-binding elements (TBE), GATA 
factor-binding sites (GATA) and nkx2–5-binding sites (nKE) are shown. 
ATG: start codon; TGA: translational stop codon. nucleotide positions 
shown are relative to start codon. (b) ChIP of Brg1 at the Nppa or Gja5 
promoters from E9.5 hearts of the indicated genotypes. on the left are 
EtBr-stained gels showing amplification, and quantitation by QPCR is 
shown in the graphs on the right. Data are mean ± s.e.; n = 3; *P < 0.05. 
(c) Quantitation of Nppa mRnA in nIH3T3 fibroblasts transfected with 
combinations of Tbx5, nkx2–5 and Gata4. Data are mean ± s.e.; n = 3; 
*P < 0.05 versus mock transfection. (d) Western blot to measure reduction 
of Brg1 protein levels by anti-Brg1 esiRnAs. Actin is a loading control.  
(e) Quantitation of Nppa mRnA in nIH3T3 fibroblasts transfected with 
Tbx5, nkx2–5 and Gata4, with or without esiRnAs targeting Brg1, or 
control esiRnAs. TFs = Tbx5, Gata4 and nkx2–5. Data are mean ± s.e.;  
n = 3; *P < 0.05 versus mock transfection; **P < 0.05 esiBrg1 +  versus 
esiBrg1 − . (f) Brg1 mRnA levels in the same samples as in c. Data are 
mean ± s.e.; n = 3; **P < 0.05 esiBrg1 +  versus esiBrg1 − .ARTICLE     
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genes  predict  that,  in  the  developing  heart,  maintaining  relative 
levels of BAF complexes and transcription factors is critical for the 
timely and precise activation of groups of genes during development.   
In human congenital heart disease, disruption of these dosage-sensi-
tive interactions would predict the impaired activation of specific gene 
networks that are essential for specific aspects of cardiac morphogen-
esis and function. We propose that an imbalance in this relationship 
is a molecular basis underlying CHDs caused by mutations in cardiac 
transcription factors. Although such a finely regulated interrelation-
ship is perhaps more prone to disruption, it confers significant advan-
tages in the fine quantitative regulation of transcript levels, which is 
an essential component of complex morphogenesis. These results 
further underscore the potential for multigenic effects on dominant 
mutations, and suggest that polymorphisms in BAF complex subunit 
genes, including but not restricted to Brg1, may modulate the pen-
etration and phenotypic consequence of disease-causing mutations 
in transcription factor genes in human populations.
Methods
Mouse strains and embryology. The following mouse strains were used: 
Brg1L2/ + 14, Nkx2–5::Cre15, Mef2cAHF::Cre26, Tbx5del/ + 4, Nkx2–5lacZ/ + 35, Tbx20 + / − 32, 
Z/EG44 and RYR45. Brg1 + / −  mice were generated by crossing Brg1L2/ −  mice with EIIa-
Cre mice46. For all experimental analyses, at least three embryos per genotype were 
examined. All animal experiments were conducted following guidelines established 
and approved by the UCSF Institutional Animal Care and Use Committee, and in 
accordance with best practices outlined by the Canadian Council on Animal Care 
and licensed by Lab Animal Services at the Hospital for Sick Children.
Analysis of protein and mRNA expression. Immunostaining and in situ hybridi-
zation procedures were carried out by standard protocols. For immunostaining, 
cryosections were incubated with primary antisera against enhanced green fluo-
rescent protein (EGFP; Abcam ab13970, 1:300) and with alpha-tropomyosin (CH1 
monoclonal, Hybridoma bank, 1:50), followed by incubation with Alexa Fluor 
488-coupled goat-anti-chicken immunoglobulin (Ig) G (Invitrogen A11039, 1:200) 
and Alexa Fluor 594-coupled goat anti-mouse IgG (Invitrogen A110320), and were 
mounted with Prolong gold with 4,6-diamidino-2-phenylindole (Invitrogen), to 
stain nuclei. In situ hybridization by whole mount or on 10 µm paraffin sections was 
performed using previously described protocols47. RNA probes were labelled with 
digoxigenin-labelled UTP, hybridized to samples and after washes were incubated 
with alkaline phosphatase-coupled anti-digoxigenin antisera (Roche); colorimetric 
detection was carried out by incubation with BM purple (Roche). Optical projection 
tomography (OPT) was performed as described7 using embryos labelled for alpha-
cardiac actin (Actc) by fluorescent in situ hybrization (using the TSA amplification 
system, Amersham). OPT images were acquired in the GFP channel for tissue 
autofluorescence, and in the red channel for Actc fluorescence. Three-dimensional 
reconstructions were analysed and rendered in Amira 4.0 (Visage Imaging).  
QRT-PCR was performed with Taqman probe sets (Supplementary Table S1).
Cardiac physiology. Cardiac function was assessed by high-frequency ultrasound 
and telemetry ECG4,27. For ultrasound assessment of cardiac function, a high-
frequency ultrasound imaging system (Vevo 660, VisualSonics) with a 30 MHz 
transducer was used for in vivo evaluation of cardiac morphology and function as 
previously described in detail27 Mice were anaesthetized with isoflurane at 1.5% by 
face mask, and body temperature was maintained at ~37 °C. An M-mode recording 
of the left ventricle was made in long-axis view and analysed for wall thickness 
and chamber dimension. Fractional shortening was also calculated as a measure 
of left ventricular systolic function. Mitral Doppler flow spectrum was recorded in 
apical four-chamber view, with the Doppler sample volume placed at the centre of 
mitral orifice and at the tip level of the valves for the highest velocities. The peak 
velocities of the early ventricular filling wave (E wave) and the late ventricular 
filling wave caused by atrial contraction (A wave) were measured, and their ratio 
was calculated. The left ventricular systolic and diastolic time intervals were also 
measured, including the isovolumic relaxation time, ventricular diastolic filling 
time, isovolumic contraction time and ventricular ejection time. All parameters 
were averaged for three cardiac cycles.
For ECG telemetry, telemetry devices (DSI) were implanted subcutaneously 
dorsally under anaesthesia (sodium pentobarbital, 0.033 mg g − 1 i.p.), and the l 
eads were placed in lead II conformation. Following a 72 h recovery period, mice  
housed in individual cages were placed on telemetry detection platforms and  
continuous ECG tracings were acquired for 24 h. ECGs were manually examined 
for arrhythmias. Ultrasound measurements and ECG intervals were calculated 
during periods of regular sinus rhythm.
Zebrafish embryology and genetics. The brg1s481 allele was identified in a diploid 
ENU mutagenesis screen for mutations affecting endodermal organ morphogenesis48. 
A C-to-T base-pair change at position 754 in the brg1 (smarca4) coding sequence 
creates a premature STOP codon at amino acid 252. MOs targeting brg1 and p53 have 
been previously published and validated20,21. RNA in situ hybridization probes for 
myl7/cmlc2, nppa, bmp4, tbx2b and notch1b have been characterized49,50. For the ncx1h 
(slc8a1a) probe, a 560 bp PCR product amplified from cDNA was used as a template.
For mosaic labelling of cardiomyocytes, embryos from Tg(cmlc2:eGFPtwu34) + / +  
in-crosses were injected at the one-cell stage with 10 pg of pBISceI-cmlc2:dsRed 
plasmid DNA with I SceI enzyme (NEB) in I SceI buffer.
For time-lapse analysis, Tg(cmlc2:eGFP) control embryos or morphants were 
mounted in agarose, and imaged at 28.5 °C using a 25× water objective. To count 
cardiomyocytes at various stages, we used the Tg(cmlc2:dsRedExp-nuchsc4) line. 
Mounted embryos were imaged with a 40× water immersion lens. Sequential  
confocal images were taken with a standardized step size of 0.65 ìm in the  
z-direction. Quantification of myocardial cells, cell migration tracking and  
three-dimensional reconstructions of confocal stacks were carried out using  
Volocity (Improvision).
Microarrays and statistical analysis. Affymetrix mouse Gene ST 1.0 arrays 
were hybridized and scanned according to the manufacturer’s recommendations. 
Raw intensities from CEL files were analysed using Affymetrix Power Tools (APT, 
version 1.10.1) to generate robust multiarray average51 expression intensities on 
a log-2 scale for each probe set and various quality metrics. The probe intensities 
were background-corrected, quantile-normalized and summarized for each probe 
set using a robust fit of linear models. Linear models were fitted for each gene to 
estimate genotype effects and associated significance using the limma package52 in 
R/Bioconductor. Because sample sizes are often small in microarray experiments, 
the eBayes function in limma computes s.e. that are moderated across all genes on 
the array. The interpretation of the moderated t-statistics is the same as an ordinary 
t-statistics. Nkx2–5/Brg1 and Tbx5/Brg1 experiments were analysed separately us-
ing 2×2 factorial models. Linear contrasts were used to extract comparisons of in-
terest. P-values were adjusted for multiple testing by controlling for false-discovery 
rate using the Benjamini–Hochberg method53. Genes differentially expressed  > 1.3-
fold with adjusted P < 0.01 were considered significantly different between groups. 
QRT-PCR and ChIP data were analysed by analysis of variance, followed by post 
hoc Tukey’s test; P < 0.05 was considered significant. Pairwise comparisons were 
made using t-test; P < 0.05 was considered significant.
Clustering and pathway analysis. Genes that were declared to be differently 
expressed were subjected to unsupervized cluster analysis with the R package 
HOPACH54. All biological replicates within groups were included in cluster 
analyses. Pearson’s correlations between genes were used as the distance metric, 
and default settings were used for other parameters. Clusters with similar  
expression patterns between genotypes were collapsed for further analysis.  
GOElite (www.genmapp.org/go_elite/go_elite.html/) was used to identify over-
represented gene ontology terms and pathways among the sets of differentially 
expressed genes. All genes that were subjected to expression analysis were used 
as the ‘denominator’ gene list for detecting overrepresentation. Null distributions 
were derived by permutation (n = 2000). Significance was assessed using false-
discovery rate-adjusted P-values.
Cell culture and ChIP. NIH/3T3 mouse embryonic fibroblasts were seeded in a 24-
well format at 40,000 cells per well; 2 days after seeding, cells were transfected us-
ing Lipofectamine 2000 reagent (Invitrogen) with a combination of HA-Tbx5, myc-
GATA4 and FLAG-Nkx2–5 overexpression plasmids (200 ng) or empty pcDNA3.1 −  
(600 ng total). esiRNAs were generated as described37; briefly, regions of EGFP or 
Brg1 were amplified by PCR (using the following primers: eGFP_esi1 (forward): 
5′-TAATACGACTCACTATAGGGCGTAAACGGCCACAAGTTCA-3′; eGFP_esi2 
(reverse): 5′-TAATACGACTCACTATAGGGATGGGGGTGTTCTGCTGGTA-3′; 
Brg1 esiRNA (forward): 5′-GGGCGGGTGTGTCCCTGTACAACAACAACC-3′; 
Brg1 esiRNA (reverse): 5′-GGGCGGGTCTGCAGCTCTTGAAGATAGTGG-3′. 
Brg1 PCR products were further amplified with an adaptor primer containing T7 
sequences (5′-TAATACGACTCACTATAGGGAGACCACGGGCGGGT-3′). EGFP 
and Brg1 products were then purified using a Qiagen PCR Clean Up kit and were 
in vitro transcribed using T7 RNA polymerase (Roche). Transcribed RNA was 
annealed to yield double stranded RNA. After purification (Roche; Quick Spin 
Columns), 10 µg of double stranded RNA was subjected to digestion using purified 
glutathione S-transferase (GST)-RNAse III fusion protein and purified by ethanol 
precipitation to generate pools of 21 bp esiRNAs.
In knockdown experiments, 450 ng of either esiGFP or esiBrg1 was transfected. 
Relative expression was determined by quantitative PCR using TaqMan probes 
against Nppa and Brg1; expression was normalized to β-actin (probe-set details in 
Supplementary Table S1). Each reaction was performed in technical triplicate.
ChIP was performed as previously described8, using chromatin isolated from 
E12.5 embryonic hearts, with anti-Brg1 antiserum (Upstate 07-478) or normal rab-
bit IgG (Santa Cruz 2027), using 1 µg of antiserum. PCR was performed using the 
following primers: Nppa-595F: 5′-TCTTTCACCTGACTGCTAACA-3′, Nppa-12R: 
5′-AGCATCTCCCGTTTTTATAG-3′; Gja5-F1: 5′-ACGACTGTGGCAGCA 
GGTGTTCTGC-3′, Gja5-R1: 5′-AGAACCAGCAGGTGCCCTTTCCCCT-3′. 
Amplicons were 573 bp long for Nppa and 583 bp long for Gja5. Quantification 
was performed using the same primers and SYBR green quantification. ARTICLE
0
nATuRE CommunICATIons | DoI: 10.1038/ncomms1187
nATuRE CommunICATIons | 2:187 | DoI: 10.1038/ncomms1187 | www.nature.com/naturecommunications
© 2011 Macmillan Publishers Limited. All rights reserved.
References
1.  Olson, E. N. Gene regulatory networks in the evolution and development of the 
heart. Science 313, 1922–1927 (2006).
2.  Srivastava, D. Making or breaking the heart: from lineage determination to 
morphogenesis. Cell 126, 1037–1048 (2006).
3.  Bruneau, B. G. The developmental genetics of congenital heart disease. Nature 
451, 943–948 (2008).
4.  Bruneau, B. G. et al. A murine model of Holt-Oram syndrome defines roles 
of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106, 
709–721 (2001).
5.  Garg, V. et al. GATA4 mutations cause human congenital heart defects and 
reveal an interaction with TBX5. Nature 424, 443–447 (2003).
6.  Hiroi, Y. et al. Tbx5 associates with Nkx2-5 and synergistically promotes 
cardiomyocyte differentiation. Nat. Genet. 28, 276–280 (2001).
7.  Lickert, H. et al. Baf60c is essential for function of BAF chromatin remodelling 
complexes in heart development. Nature 432, 107–112 (2004).
8.  Takeuchi, J. K. & Bruneau, B. G. Directed transdifferentiation of mouse 
mesoderm to heart tissue by defined factors. Nature 459, 708–711 (2009).
9.  Lessard, J. et al. An essential switch in subunit composition of a chromatin 
remodeling complex during neural development. Neuron 55, 201–215 
(2007).
10. Ho, L. & Crabtree, G. R. Chromatin remodelling during development. Nature 
463, 474–484 (2010).
11. Bruneau, B. G. Chromatin remodeling in heart development. Curr. Opin. 
Genet. Dev. 20, 505–511 (2010).
12. Reyes, J. C. et al. Altered control of cellular proliferation in the absence of 
mammalian brahma (SNF2alpha). EMBO J. 17, 6979–6991 (1998).
13. Bultman, S. et al. A Brg1 null mutation in the mouse reveals functional 
differences among mammalian SWI/SNF complexes. Mol. Cell 6, 1287–1295 
(2000).
14. Indra, A. K. et al. Temporally controlled targeted somatic mutagenesis in 
embryonic surface ectoderm and fetal epidermal keratinocytes unveils two 
distinct developmental functions of BRG1 in limb morphogenesis and skin 
barrier formation. Development 132, 4533–4544 (2005).
15. McFadden, D. G. et al. The Hand1 and Hand2 transcription factors regulate 
expansion of the embryonic cardiac ventricles in a gene dosage-dependent 
manner. Development 132, 189–201 (2004).
16. Ieda, M. et al. Cardiac fibroblasts regulate myocardial proliferation through 
beta1 integrin signaling. Dev. Cell 16, 233–244 (2009).
17. Hang, C. T. et al. Chromatin regulation by Brg1 underlies heart muscle 
development and disease. Nature 466, 62–67 (2010).
18. Link, B. A., Fadool, J. M., Malicki, J. & Dowling, J. E. The zebrafish young 
mutation acts non-cell-autonomously to uncouple differentiation from 
specification for all retinal cells. Development 127, 2177–2188 (2000).
19. Gregg, R. G., Willer, G. B., Fadool, J. M., Dowling, J. E. & Link, B. A. Positional 
cloning of the young mutation identifies an essential role for the Brahma 
chromatin remodeling complex in mediating retinal cell differentiation.  
Proc. Natl Acad. Sci. USA 100, 6535–6540 (2003).
20. Eroglu, B., Wang, G., Tu, N., Sun, X. & Mivechi, N. F. Critical role of 
Brg1 member of the SWI/SNF chromatin remodeling complex during 
neurogenesis and neural crest induction in zebrafish. Dev. Dyn. 235, 
2722–2735 (2006).
21. Plaster, N., Sonntag, C., Busse, C. E. & Hammerschmidt, M. p53 deficiency 
rescues apoptosis and differentiation of multiple cell types in zebrafish flathead 
mutants deficient for zygotic DNA polymerase delta1. Cell Death Differ. 13, 
223–235 (2006).
22. Auman, H. J. et al. Functional modulation of cardiac form through regionally 
confined cell shape changes. PLoS Biol. 5, e53 (2007).
23. Bolck, B. et al. Na+/Ca2+ exchanger overexpression impairs frequency- and 
ouabain-dependent cell shortening in adult rat cardiomyocytes. Am. J. Physiol. 
Heart Circ. Physiol. 287, H1435–1445 (2004).
24. Reuter, H., Han, T., Motter, C., Philipson, K. D. & Goldhaber, J. I. Mice 
overexpressing the cardiac sodium-calcium exchanger: defects in excitation-
contraction coupling. J. Physiol. 554, 779–789 (2004).
25. Baker, K., Holtzman, N. G. & Burdine, R. D. Direct and indirect roles for nodal 
signaling in two axis conversions during asymmetric morphogenesis of the 
zebrafish heart. Proc. Natl Acad. Sci. USA 105, 13924–13929 (2008).
26. Verzi, M. P., McCulley, D. J., De Val, S., Dodou, E. & Black, B. L. The right 
ventricle, outflow tract, and ventricular septum comprise a restricted 
expression domain within the secondary/anterior heart field. Dev. Biol. 287, 
437–449 (2005).
27. Zhou, Y. Q. et al. Abnormal cardiac inflow patterns during postnatal 
development in a mouse model of Holt-Oram syndrome. Am. J. Physiol. Heart 
Circ. Physiol. 289, H992–H1001 (2005).
28. Zhu, Y. H. et al. Tbx5-dependent pathway regulating diastolic function in 
congenital heart disease. Proc. Natl Acad. Sci. USA 105, 5519–5524 (2008).
29. Garrity, D. M., Childs, S. & Fishman, M. C. The heartstrings mutation in 
zebrafish causes heart/fin Tbx5 deficiency syndrome. Development 129, 
4635–4645 (2002).
30. Biben, C. et al. Cardiac septal and valvular dysmorphogenesis in mice 
heterozygous for mutations in the homeobox gene Nkx2-5. Circ. Res. 87, 
888–895 (2000).
31. Jay, P. Y. et al. Nkx2-5 mutation causes anatomic hypoplasia of the cardiac 
conduction system. J. Clin. Invest. 113, 1130–1137 (2004).
32. Stennard, F. A. et al. Murine T-box transcription factor Tbx20 acts as a 
repressor during heart development, and is essential for adult heart integrity, 
function and adaptation. Development 132, 2451–2462 (2005).
33. Reiter, J. F. et al. Gata5 is required for the development of the heart and 
endoderm in zebrafish. Genes Dev. 13, 2983–2995 (1999).
34. Mori, A. D. et al. Tbx5-dependent rheostatic control of cardiac gene expression 
and morphogenesis. Dev. Biol. 297, 566–586 (2006).
35. Tanaka, M., Chen, Z., Bartunkova, M., Yamazaki, N. & Izumo, S. The cardiac 
homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes 
essential for heart development. Development 126, 1269–1280 (1999).
36. Durocher, D., Charron, F., Warren, R., Schwartz, R. J. & Nemer, M. The cardiac 
transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J. 16, 
5687–5696 (1997).
37. Yang, D. et al. Short RNA duplexes produced by hydrolysis with Escherichia coli 
RNase III mediate effective RNA interference in mammalian cells. Proc. Natl 
Acad. Sci. USA 99, 9942–9947 (2002).
38. Chi, T. H. et al. Sequential roles of Brg, the ATPase subunit of BAF chromatin 
remodeling complexes, in thymocyte development. Immunity 19, 169–182 
(2003).
39. Gebuhr, T. C. et al. The role of Brg1, a catalytic subunit of mammalian 
chromatin-remodeling complexes, in T cell development. J. Exp. Med. 198, 
1937–1949 (2003).
40. Seo, S., Richardson, G. A. & Kroll, K. L. The SWI/SNF chromatin remodeling 
protein Brg1 is required for vertebrate neurogenesis and mediates 
transactivation of Ngn and NeuroD. Development 132, 105–115 (2005).
41. Griffin, C. T., Brennan, J. & Magnuson, T. The chromatin-remodeling 
enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular 
development. Development 135, 493–500 (2008).
42. Stankunas, K. et al. Endocardial Brg1 represses ADAMTS1 to maintain the 
microenvironment for myocardial morphogenesis. Dev. Cell 14, 298–311 
(2008).
43. Chi, T. H. et al. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like 
BAF complexes. Nature 418, 195–199 (2002).
44. Novak, A., Guo, C., Yang, W., Nagy, A. & Lobe, C. G. Z/EG, a double reporter 
mouse line that expresses enhanced green fluorescent protein upon Cre-
mediated excision. Genesis 28, 147–155 (2000).
45. Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP 
and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).
46. Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at 
the zygote stage. Proc. Natl Acad. Sci USA 93, 5860–5865 (1996).
47. Riddle, R. D., Johnson, R. L., Laufer, E. & Tabin, C. Sonic hedgehog mediates 
the polarizing activity of the ZPA. Cell 75, 1401–1416 (1993).
48. Ober, E. A., Verkade, H., Field, H. A. & Stainier, D. Y. Mesodermal Wnt2b 
signalling positively regulates liver specification. Nature 442, 688–691 (2006).
49. Berdougo, E., Coleman, H., Lee, D. H., Stainier, D. Y. & Yelon, D. Mutation 
of weak atrium/atrial myosin heavy chain disrupts atrial function and 
influences ventricular morphogenesis in zebrafish. Development 130, 
6121–6129 (2003).
50. Yelon, D., Horne, S. A. & Stainier, D. Y. Restricted expression of cardiac myosin 
genes reveals regulated aspects of heart tube assembly in zebrafish. Dev. Biol. 
214, 23–37 (1999).
51. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density 
oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003).
52. Smyth, G. K. Linear models and empirical bayes methods for assessing 
differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 
3, Article3 (2004).
53. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical 
and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289–300 
(1995).
54. Pollard, K. S. & M. J., van der Laan. in Bioinformatics and Computational 
Biology Using R and Bioconductor (eds Gentleman, R. et al.) Ch. 13 Springer, 
2005).
Acknowledgments
We thank T. Sukonnik for immunostaining, D. Miguel-Perez for mouse husbandry, S. 
Izumo and E.N. Olson for providing mice, B. Panning for esiRNA primers and protocols, 
B.L. Black and D. Srivastava for critical comments on the manuscript, the Gladstone 
Genomics Core (Y. Hao and L. Ta) and the Gladstone Histology Core (C. Miller and J.-D. 
Fish) for excellent services, and G. Howard and S. Ordway for editorial assistance. The 
CH1 monoclonal antibody developed by J.J.C. Lin was obtained from the Developmental 
Studies Hybridoma Bank, The University of Iowa. This work was supported by a 
California Institute for Regenerative Medicine Fellowship (P.D-O.); a Heart and Stroke 
Richard Lewar Centre of Excellence in Cardiovascular Research fellowship (X.L.); grants ARTICLE     

nATuRE CommunICATIons | DoI: 10.1038/ncomms1187
nATuRE CommunICATIons | 2:187 | DoI: 10.1038/ncomms1187 | www.nature.com/naturecommunications
© 2011 Macmillan Publishers Limited. All rights reserved.
from the NIH/NHLBI (R01 HL54737 to D.Y.R.S., R01 HL085860 to B.G.B.), Human 
Frontiers Science Program CDA (J.K.T.), Japan Circulation Foundation (J.K.T.), TORAY 
Foundation (J.K.T. and H.S.) and CIHR Institute of Genetics (Operating Grant 86663 to 
I.C.S.). B.G.B. is the recipient of the Lawrence J. and Florence A. DeGeorge Charitable 
Trust/American Heart Association Established Investigator Award. This work was also 
supported by an NIH/NCRR grant (C06 RR018928) to the J. David Gladstone Institutes 
and by William H. Younger, Jr (B.G.B.).
Author contributions
J.K.T. and B.G.B. designed the study. J.K.T. performed most of the work on mice. X.L. 
carried out most of the work on zebrafish, under the direction of I.C.S. C.M. isolated the 
zebrafish brg1 mutation under the direction of D.Y.R.S. J.M.A. and P.D.-O. performed cell 
culture assays. H.S. performed chromatin immunoprecipitation under the direction of 
J.K.T. A.K.H., R.-F.Y. and K.S.P. designed and performed bioinformatics analysis of array 
data. RNA isolation and preparation were performed by A.D.M. and J.N.W. R.P.H., D.M. 
and P.C. provided genetically modified mouse strains. Y.Z. and Y.-Q.Z. performed mouse 
physiological measurements under the direction of B.G.B. and R.M.H., respectively. 
B.G.B. wrote the paper with contributions from all authors.
Additional information
Accession codes: Microarray data have been deposited in GEO under the accession 
number GSE26191.
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing financial interests: The authors declare no competing financial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Takeuchi, J. K. et al. Chromatin remodelling complex dosage 
modulates transcription factor function in heart development. Nat. Commun. 2:187  
doi: 10.1038/ncomms1187 (2011).
License: This work is licensed under a Creative Commons Attribution-NonCommercial-
Share Alike 3.0 Unported License. To view a copy of this license, visit http://
creativecommons.org/licenses/by-nc-sa/3.0/